IntelliPharmaCeutics International (TSXV:IPCI) Purchase Of Business : C$0.00 Mil (TTM As of Aug. 2023)

View and export this data going back to 1999. Start your Free Trial

What is IntelliPharmaCeutics International Purchase Of Business?

IntelliPharmaCeutics International's purchase of business for the three months ended in Aug. 2023 was C$0.00 Mil. It means IntelliPharmaCeutics International spent C$0.00 Mil on purchasing business. IntelliPharmaCeutics International's purchase of business for the trailing twelve months (TTM) ended in Aug. 2023 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in May. 2023 ), IntelliPharmaCeutics International spent the same money on purchasing business in Aug. 2023 (C$0.00 Mil).

IntelliPharmaCeutics International Purchase Of Business Historical Data

The historical data trend for IntelliPharmaCeutics International's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Purchase Of Business Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Purchase Of Business

Get a 7-Day Free Trial

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Purchase Of Business	Get a 7-Day Free Trial															-	-	-	-	-

IntelliPharmaCeutics International Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

IntelliPharmaCeutics International Purchase Of Business Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (TSXV:IPCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (TSXV:IPCI) » Definitions » Purchase Of Business

Comparable Companies

Traded in Other Exchanges

IPCIF:USA I4AA:Germany

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (TSXV:IPCI) Headlines

No Headlines